References
- Alayash AI. 2014. Blood substitutes: why haven't we been more successful? Trends Biotechnol. 32:177–185.
- Cabrales P, Tsai AG, Intaglietta M. 2008. Isovolemic exchange transfusion with increasing concentrations of low oxygen affinity hemoglobin solution limits oxygen delivery due to vasoconstriction. Am J Physiol Heart Circ Physiol. 295:H2212–2218.
- Cabrales P, Tsai AG, Intaglietta M. 2009. Polymerized bovine hemoglobin can improve small-volume resuscitation from hemorrhagic shock in hamsters. Shock. 31:300–307.
- Chang TM. 2005. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 4:221–235.
- Elmer J, Alam HB, Wilcox SR. 2012. Hemoglobin-based oxygen carriers for hemorrhagic shock. Resuscitation. 83:285–292.
- Huang Y, Komatsu T, Yamamoto H, Horinouchi H, Kobayashi K, Tsuchida E. 2006. PEGylated albumin-heme as an oxygen- carrying plasma expander: Exchange transfusion into acute anemia rat model. Biomaterials. 27:4477–4483.
- Li T, Yu R, Zhang HH, Wang H, Liang WG, Yang XM, et al. 2006. A method for purification and viral inactivation of human placenta hemoglobin. Artif Cells Blood Substit Immobil Biotechnol. 34: 175–188.
- Li T, Zhang Z, Wu W, Liao D, Chen Y, Li S, et al. 2013. Resuscitation with polymerized human placenta hemoglobin attenuated hemorrhagic shock-induced lung injury. Artif Cells Nanomed Biotechnol. 41:27–31.
- Li T, Li J, Liu J, Zhang P, Wu W, Zhou R, et al. 2009. Polymerized placenta hemoglobin attenuates ischemia/reperfusion injury and restores the nitroso-redox balance in isolated rat heart. Free Radic Biol Med. 46:397–405.
- Murdock AD, Berseus O, Hervig T, Strandenes G, Lunde TH. 2014. Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock. 41 Suppl 1:62–69.
- Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, et al. 2004. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med. 32:539–545.
- Squires JE. 2002. Artificial blood. Science. 295:1002–1005.
- Vazquez BY, Hightower CM, Martini J, Messmer C, Frienesenecker B, Corbels P, et al. 2011. Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock. Crit Care Med. 39:1461–1466.
- Wettstein R, Tsai AG, Erni D, Winslow RM, Intaglietta M. 2003. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med. 31:1824–1830.
- Wettstein R, Tsai AG, Harder Y, Erni D, Intaglietta M. 2006. Early resuscitation with polymerized bovine hemoglobin reverses acidosis, but not peripheral tissue oxygenation, in a severe hamster shock model. Shock. 26:496–503.
- Winslow RM. 2003. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects. Curr Hematol Rep. 2: 503–510.
- You Z, Li Q, Li B, Yang C, Liu J, Li T. 2014. Isovolemic hemodilution with glutaraldehyde-polymerized human placenta hemoglobin (PolyPHb) attenuated rat liver ischemia/reperfusion injury. Artif Cells Nanomed Biotechnol. 42:83–87.
- Zhao L, Wang B, You G, Wang Z, Zhou H. 2009. Effects of different resuscitation fluids on the rheologic behavior of red blood cells, blood viscosity and plasma viscosity in experimental hemorrhagic shock. Resuscitation. 80:253–258.
- Zhou W, Li S, Hao S, Liu J, Wang H, Yang C. 2014. An optimal polymerization process for low mean molecular weight HBOC with lower dimer. Artif Cells Nanomed Biotechnol.18:1–4.
- Zhou W, Zhao L, Wang J, Li S, Chen G, Liu J, Yang C. 2013. An optimal polymerization conditions for poly-human placenta hemoglobin with lower mean molecular weight. Artif Cells Nanomed Biotechnol. 41:289–292.